Osteoporosis Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• The person is a woman who has gone through menopause, has not had a period for at least one year, and is between 65 and 91 years old.
• The person has had a hip fracture caused by a minor incident (such as a low-level fall) and is scheduled to have surgery to repair that hip.
• The person has at least one additional factor that raises the risk of a future hip fracture, such as: being assessed as moderate or high risk for falls; having fallen two or more times in the past year; having a history of vertigo, dizziness, or low blood pressure when standing; having a bone density scan result showing significant bone loss at the hip; taking more than three prescription medications daily; having vision problems (such as difficulty seeing, loss of depth perception, vision in only one eye, macular degeneration, or cataracts); having had a previous fracture in a bone other than the hip; having mild memory or thinking difficulties or delirium; having Parkinson's disease at stage 3 or 4; or having a 10-year hip fracture risk score above 15% based on a standard fracture risk calculation tool.
• The person is expected to be able to walk — even with the help of a walking aid — after the hip repair surgery, beyond just basic movements like getting in and out of a chair.
• Informed consent has been provided by the person themselves, or by a legally authorised representative on their behalf — and if a representative provides consent, the person must still be able to understand and follow the post-surgery requirements.
• The person's willingness and ability to attend all study visits and follow-up appointments for the full length of the study has been documented.

Who may not be able to join:

• The person is currently taking part in another clinical trial that involves the hip being treated in this study.
• The person has previously had hip surgery or a hip fracture on the opposite hip to the one that is fractured now.
• The person has additional new fractures (beyond the current hip fracture) that, in the treating doctor's opinion, would interfere with recovery or rehabilitation.
• The person has an infection, broken skin, or an open wound near the area of the body where the study treatment would be applied.
• The person has had a gradually worsening, unexplained pain in the opposite hip over the past three months that the doctor thinks may indicate an underlying bone or joint problem on that side.
• Imaging scans show significant bone or joint problems in the hip, including signs that may suggest a particular type of unusual fracture, or the person has already been diagnosed or treated for that type of fracture.
• The person has a bone disease other than osteoporosis, such as Paget's disease, a bone condition related to kidney disease, or a softening of the bones condition.
• The person currently has active cancer.
• The person has very severe kidney disease, defined by a specific kidney function measurement falling below a certain level (confirm with trial site).
• The person has moderate or severe difficulties with memory or thinking, as measured by a standard short test.
• The person has a known allergy to calcium-based materials used to fill bone.
• In the doctor's judgement, the person is not a suitable candidate for the study — for example, due to significant mental health concerns, active alcohol or drug misuse, or because the person's current overall health would not support an elective orthopaedic surgical procedure.
• The person does not meet specific eligibility checks carried out before or during surgery, as outlined in the study plan (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.